HC asks Centre, AAP govt about scarcity of Remdesivir vials in Delhi

The Delhi High Court Tuesday asked the Centre and AAP government as to why there was Remdesivir drug scarcity in the national capital when the medication was being widely prescribed for Covid patients

Remdesivir
Press Trust of India New Delhi
2 min read Last Updated : Apr 28 2021 | 5:02 PM IST

The Delhi High Court Tuesday asked the Centre and AAP government as to why there was Remdesivir drug scarcity in the national capital when the medication was being widely prescribed for COVID-19 patients whose numbers have surged hugely in the past few days.

On being told by the Centre that Remdesivir can only be administered at hospitals, the high court observed that when oxygen and beds were not available in hospitals for coronavirus patients, then how will they get the drug.

Justice Prathiba M Singh made the Health Ministry and the Drug Controller General of India (DCGI) a party in the matter and asked their lawyers to come with instructions on why there was a scarcity of the drug in Delhi.

A similar direction was issued to additional standing counsel Anuj Aggarwal, appearing for the Delhi government, and the matter was listed for hearing post lunch by the court.

"Entire city is suffering as they are not getting this drug. Entire procurement is done by the government. Then why is this happening," the court asked Aggarwal when the hearing commenced.

Aggarwal said that Delhi does not have the facilities to manufacture the drug and it is obtained from other states who sell it only after meeting their own demands.

He also told the court that a large stock of the drug had expired in February this year as it was not being actively prescribed by doctors.

The court, however, did not agree with the submission regarding the medicine not being prescribed, saying the drug was being prescribed by doctors everywhere.

The court also asked, "Was it not permitted by the Indian Council of Medical Research (ICMR)?"

The court was hearing a plea moved by a lawyer who is suffering from COVID-19 and was able to get only three out of the six doses of Remdesivir required by him.

In his plea, he has sought directions to the Delhi government to provide him with the remaining doses of the drug.

During the pre-noon hearing, the central government told the court that the drug can only be administered in a hospital setting and therefore, how were people getting it from pharmacies.

To this, the court said, "There are no beds or oxygen available in the hospitals.

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusDelhi High CourtAAPRemdesivir

First Published: Apr 27 2021 | 1:12 PM IST

Next Story